Welcome to our dedicated page for Exelon SEC filings (Ticker: EXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Exelon Corporation (EXC) files a range of documents with the U.S. Securities and Exchange Commission that shed light on its operations as a Fortune 200 utility and parent of six fully regulated transmission and distribution companies. On this SEC filings page, you can review Exelon’s Forms 8-K, along with references to its annual reports on Form 10-K and quarterly reports on Form 10-Q, to better understand the company’s regulatory and financial disclosures.
Recent Form 8-K filings illustrate how Exelon uses current reports to communicate material events. These include combined filings for Exelon and its utilities—Commonwealth Edison (ComEd), PECO, BGE, Pepco Holdings, Potomac Electric Power Company, Delmarva Power & Light and Atlantic City Electric—when announcing quarterly results and related earnings presentations. Other 8-Ks describe matters such as a preliminary court approval of a proposed settlement of a consolidated stockholder derivative action, a temporary blackout period for the Employee Savings Plan tied to a vendor change, and changes in executive responsibilities for compliance, audit and risk.
Filings also reference Exelon’s capital markets activity. The company has reported an offering and pricing of convertible senior notes due 2029 in a private placement, outlining the terms of these senior unsecured obligations and stating that net proceeds are intended for debt repayment, refinancing or general corporate purposes. Such disclosures help investors track Exelon’s financing strategy and capital structure.
Through Stock Titan, users can access Exelon’s real-time SEC submissions as they are posted to EDGAR, including 10-K and 10-Q reports, 8-K current reports and exhibits. AI-powered summaries highlight key points from lengthy filings, such as risk factor discussions, legal proceedings, governance changes and financing terms, allowing readers to quickly identify items relevant to EXC’s regulated utility operations and corporate governance.
Exelon Corporation reported the results of its Annual Meeting of Shareholders held on April 28, 2026. Shareholders of record as of March 2, 2026, were entitled to vote.
All nominated directors were elected, each receiving at least 92.8% of votes cast in favor. For example, Calvin G. Butler, Jr. received 840,779,094 votes for, or 99.2% of votes cast. Auditor ratification for 2026 passed, with 818,550,440 votes for, or 89.0% of votes cast, approving PricewaterhouseCoopers LLP as independent auditor. An advisory vote on executive compensation also passed, receiving 764,185,640 votes for, or 90.5% of votes cast.
Exelon Corp ownership filing: Vanguard Capital Management reports beneficial ownership of 76,934,260 shares of Exelon common stock, representing 7.51% of the class. The filing states Vanguard has sole voting power over 10,918,572 shares and sole dispositive power over 76,934,260 shares. The disclosure attributes holdings across Vanguard Capital Management LLC and affiliated business divisions per SEC Release No. 34-39538.
Segedi Bryan K reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Bryan K. Segedi received a grant of 3,720 2026 Directors Restricted Stock Units (RSUs). These RSUs were awarded at no cash cost as part of the Exelon Long-term Incentive Plan.
The RSUs will fully vest and be settled on a 1-for-1 basis into Exelon common stock on April 28, 2027. Additional stock units will accrue through dividend reinvestment and will vest at the same time as the underlying award. Following this grant, Segedi holds 3,720 RSUs linked to Exelon common stock.
Exelon Corp director Matthew C. Rogers received an annual equity award of 3,720 restricted stock units for 2026 board service. These 2026 Directors Restricted Stock Units were granted at a $0.00 exercise price under the Exelon Long-term Incentive Plan and will fully vest and be settled in Exelon common shares on a 1-for-1 basis on April 28, 2027. The award will accumulate additional stock units through dividend reinvestment that vest with the underlying grant.
The filing also notes 739 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when Rogers’ service on Exelon’s board ends, rather than through open-market stock transactions.
RICHO ANNA reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Anna Richo reported a compensation-related equity grant and updated deferred holdings. She received 3,720 "2026 Directors Restricted Stock Units" on April 28, 2026, which are scheduled to fully vest and be settled in Exelon common stock on a 1-for-1 basis on April 28, 2027 under the Exelon Long-term Incentive Plan.
The filing also shows 7,930 deferred phantom share equivalents in a non-qualified deferred compensation plan, each linked 1-for-1 to Exelon common stock and payable in cash after her service on the board ends. No open-market buys or sells are reported in this filing.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie reported an annual equity award and deferred compensation holdings. On April 28, 2026, she received 3,720 2026 Directors Restricted Stock Units under Exelon’s Long-term Incentive Plan, vesting and settling in common stock on a 1-for-1 basis in 2027. She also holds 3,855 deferred phantom share equivalents in a non-qualified deferred compensation plan, payable in cash on a 1-for-1 basis after her service on the board ends.
Jojo Linda P reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Linda P. Jojo received a grant of restricted stock units under the Exelon Long-term Incentive Plan. On April 28, 2026, she was awarded 3,720 2026 Directors Restricted Stock Units at a price of $0.00 per unit as compensation, not an open-market purchase.
The RSUs are scheduled to fully vest on April 28, 2027 and will be settled in an equal number of Exelon common shares on a 1-for-1 basis. The award will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the underlying grant.
Exelon Corp director David G. DeWalt received an annual award of 3,720 restricted stock units (RSUs) designated as 2026 Directors Restricted Stock Units. These RSUs were granted as compensation under the Exelon Long-term Incentive Plan.
The award will fully vest on April 28, 2027 and then be settled in Exelon common stock on a 1-for-1 basis, meaning each unit converts into one share. The RSUs will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the original award. Following this grant, DeWalt holds 3,720 of these RSUs directly.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers reported routine equity-based compensation and existing deferred balances. On 2026-04-28, she received a grant of 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will fully vest and be settled in Exelon common stock on a 1-for-1 basis on 2027-04-28, and will also accrue additional stock units through dividend reinvestment that vest with the underlying award.
Rodgers also reported 10,013 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when her service on the board ends. No open-market purchases or sales were reported in this filing.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
EXELON CORP director William P. Bowers received a compensation-related equity award and reported existing deferred units. On 2026-04-28, he was granted 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will vest and be settled in Exelon common stock on a 1-for-1 basis and will accrue additional stock units through dividend reinvestment.
He also reported 20,158 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. According to the plan, these phantom share equivalents will be settled in cash on a 1-for-1 basis when his service on the board ends.